Eptifibatide

• Post Date:

  Dec 17,2018

• Expiry Date:

  Dec 17,2019

• Detailed Description:

  Cas No. :148031-34-9 Eptifibatide
  Appearance: White Powder Assay: 97%min
  Molecular Weight: 1025.2 Package: 2mg/5mg/10mg Per Vial
  Price: Negotiable
  
  Hot sale Eptifibatide Acetate 148031-34-9 With High Purity High Quality And Best Price
  Quick Detail:
  1.Alias:MAP-LYS-GLY-ASP-TRP-PRO-CYS-NH2;INTEGRELIN;Eptifibatide;N6-(Aminoiminomethyl)-N2-(3-mercapto-1-oxopropyl-L-lysylglycyl-L-a-aspartyl-L-tryptophyl-L-prolyl-L-cysteinamide;Intrifiban;N6-(AMinoiMinoMethyl)-N2-(3-Mercapto-1-oxopropyl)-L-lysylglycyl-L-.alpha.-aspartyl-L-tryptophyl-L-prolyl-L-cysteinaMideCyclic(16)-Disulfide;3-Mercaptopropionyl-HoMoarg-Gly-Asp-Trp-Pro-Cys-NH2
  2. CAS NO.: 148031-34-9
  3 . EINECS: none
  4 . Assay: 98.5% min.
  5 . Grade : Pharmaceutical Grade
  6 . Storage: Preserve in tight,light resistant containers,store in a refrigerator(2-8°C)
  7.anufacturer :Hezhong
  8 . Delivery :Express Courier
  
  
  Product description:
  
  1. Molecular Formula: C35H49N11O9S22. Molecular weight: 831.96
  3. Purity: 99% min.
  4 . Appearance: White powder
  5 . Sequence: Mpr-Harg-Gly-Asp-Trp-Pro-Cys)-NH2
  
  Application:
  
  1 . Eptifibatide is used to reduce the risk of acute cardiac ischemic events (death and/or myocardial infarction) in patients with unstable angina or non-ST-segment-elevation (e.g., non-Q-wave) myocardial infarction (i.e., non-ST-segment elevation acute coronary syndromes) both in patients who are to receive non surgery (conservative) medical treatment and those undergoing percutaneous coronary intervention (PCI).
  2 .treat the adults and the children above6 years old chronic humanity flaw virus(HIV)infects. chronic humanity flaw virus(HIV)infects.

• CAS Registry Number:

  148031-34-9

• Synonyms:

  ;[3-carbamoyl-11-{4-[(diaminomethylidene)amino]butyl}-20-(1H-indol-3-ylmethyl)-1,9,12,15,18,21-hexaoxodocosahydro-7H-pyrrolo[2,1-g][1,2,5,8,11,14,17,20]dithiahexaazacyclotricosin-17-yl]acetic acid;[(1S,4R,12S,18S,21S)-12-(4-carbamimidamidobutyl)-4-carbamoyl-21-(1H-indol-3-ylmethyl)-2,10,13,16,19,22-hexaoxo-6,7-dithia-3,11,14,17,20,26-hexaazabicyclo[21.2.1]hexacos-18-yl]acetic acid;MAP-LYS-GLY-ASP-TRP-PRO-CYS-NH2;INTEGRELIN;N6-(Aminoiminomethyl)-N2-(3-mercapto-1-oxopropyl-L-lysylglycyl-L-a-aspartyl-L-tryptophyl-L-prolyl-L-cysteinamide;[(3R,11S,17S,20S,25aS)-11-(4-carbamimidamidobutyl)-3-carbamoyl-20-(1H-indol-3-ylmethyl)-1,9,12,15,18,21-hexaoxodocosahydro-7H-pyrrolo[2,1-g][1,2,5,8,11,14,17,20]dithiahexaazacyclotricosin-17-yl]acetic acid;Eptifibatide Acetate;

• Molecular Formula:

  C₃₅H₄₉N₁₁O₉S₂

• Molecular Weight:

  831.96

• Molecular Structure:

  

• Company:

  Koffee Pharm Co., Ltd     [ China ]        

• Contact:

  Sophia

• Tel:

  +86-21-61729394

• Fax:

  +86-21-61729394

• Email:

  sophia.koffeepharm@gmail.com